CSIMarket
 
Rigel Pharmaceuticals Inc  (NASDAQ: RIGL)
 

Rigel Pharmaceuticals Inc's Customers Performance

RIGL



 
RIGL's Source of Revenues During the corresponding time, Rigel Pharmaceuticals Inc saw a revenue deteriorated by -22.6 % year on year, sequentially revenue grew by 33.81 %. While revenue at the Rigel Pharmaceuticals Inc's corporate clients

List of RIGL Customers




for the same period Rigel Pharmaceuticals Inc revnue deteriorated by -22.6 % year on year, sequentially revenue grew by 33.81 %.

List of RIGL Customers

Rigel Pharmaceuticals Inc's Business Units
Product    154.93 % of total Revenue
Contract revenues from collaborations    19.8 % of total Revenue
Gross Product    208.19 % of total Revenue
Discounts and allowances    -53.26 % of total Revenue
Delivery of drug supplies royalties and others    5.34 % of total Revenue
Royalty Delivery of Drug Supplies and Others    14.72 % of total Revenue
One Operating    174.73 % of total Revenue






Rigel Pharmaceuticals Inc's Comment on Sales, Marketing and Customers
















RIGL's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Rigel Pharmaceuticals Inc 882.02 299.77 364.23 174
SUBTOTAL 0.00 0.00 0.00 -

Sources: Rigel Pharmaceuticals Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Rigel Pharmaceuticals Inc’s corporate clients.
For your research, we’ve provided 9 tables on Rigel Pharmaceuticals Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.